NCT00971152View on ClinicalTrials.gov

Effect of a Higher Than Maximum 450IU Gonadotropin Dose in an In-vitro Fertilization Cycle

PHASE3CompletedINTERVENTIONAL
Enrollment

366

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

October 31, 2013

Study Completion Date

February 28, 2014

Conditions
Subfertility
Interventions
DRUG

menotropins for injection

comparison of different dosages

DRUG

urofollitropin for injection

comparison of different dosages

Trial Locations (1)

H4P 2S4

Ovo Fertilité, Montreal

Sponsors

Lead Sponsor

Clinique Ovo

Collaborators (1)

Ferring Pharmaceuticals
All Listed Sponsors
collaborator

Ferring Pharmaceuticals

INDUSTRY

lead

Clinique Ovo

INDUSTRY

NCT00971152 - Effect of a Higher Than Maximum 450IU Gonadotropin Dose in an In-vitro Fertilization Cycle | Biotech Hunter | Biotech Hunter